| Delaware | 001-40508 | 27-2485512 | ||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
||||||
|
500 3rd St.
Suite 510
San Francisco, CA 94107
(Address of principal executive offices, including zip code)
| ||||||||
|
(650) 549-4330
(Registrant's telephone number, including area code)
| ||||||||
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). | ||||
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). | ||||
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). | ||||
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). | ||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Class A common stock, $0.001 par value per share | DOCS | The New York Stock Exchange | ||||||||||||
| Exhibit Number | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) | |||||||
| DOXIMITY, INC. | ||||||||
| By: | /s/ Anna Bryson |
|||||||
|
Anna Bryson
Chief Financial Officer
|
||||||||
| December 31, 2024 | March 31, 2024 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 165,270 | $ | 96,785 | |||||||
| Marketable securities | 679,670 | 666,115 | |||||||||
| Accounts receivable, net | 137,504 | 101,332 | |||||||||
| Prepaid expenses and other current assets | 30,259 | 48,709 | |||||||||
| Total current assets | 1,012,703 | 912,941 | |||||||||
| Property and equipment, net | 13,477 | 12,318 | |||||||||
| Deferred income tax assets | 43,079 | 45,068 | |||||||||
| Operating lease right-of-use assets | 9,332 | 12,332 | |||||||||
| Intangible assets, net | 24,134 | 27,317 | |||||||||
| Goodwill | 67,940 | 67,940 | |||||||||
| Other assets | 1,492 | 1,458 | |||||||||
| Total assets | $ | 1,172,157 | $ | 1,079,374 | |||||||
| Liabilities and Stockholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 1,636 | $ | 2,253 | |||||||
| Accrued expenses and other current liabilities | 42,793 | 43,703 | |||||||||
| Deferred revenue, current | 69,197 | 99,145 | |||||||||
| Operating lease liabilities, current | 2,255 | 2,149 | |||||||||
| Total current liabilities | 115,881 | 147,250 | |||||||||
| Deferred revenue, non-current | 73 | 211 | |||||||||
| Operating lease liabilities, non-current | 10,692 | 12,397 | |||||||||
| Contingent earn-out consideration liability, non-current | 5,498 | 10,895 | |||||||||
| Other liabilities, non-current | 8,893 | 7,224 | |||||||||
| Total liabilities | 141,037 | 177,977 | |||||||||
| Stockholders' Equity | |||||||||||
| Preferred stock | — | — | |||||||||
| Common stock | 188 | 187 | |||||||||
| Additional paid-in capital | 878,701 | 823,885 | |||||||||
| Accumulated other comprehensive income (loss) | 1,015 | (2,664) | |||||||||
| Retained earnings | 151,216 | 79,989 | |||||||||
Total stockholders’ equity |
1,031,120 | 901,397 | |||||||||
| Total liabilities and stockholders’ equity | $ | 1,172,157 | $ | 1,079,374 | |||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Revenue | $ | 168,603 | $ | 135,284 | $ | 432,111 | $ | 357,365 | |||||||||||||||
Cost of revenue(1) |
14,181 | 12,190 | 41,407 | 38,102 | |||||||||||||||||||
| Gross profit | 154,422 | 123,094 | 390,704 | 319,263 | |||||||||||||||||||
Operating expenses(1): |
|||||||||||||||||||||||
| Research and development | 22,421 | 19,946 | 68,235 | 61,835 | |||||||||||||||||||
| Sales and marketing | 38,491 | 34,956 | 108,102 | 99,612 | |||||||||||||||||||
| General and administrative | 13,585 | 9,641 | 32,943 | 27,854 | |||||||||||||||||||
Restructuring and impairment charges |
— | — | 2,304 | 7,936 | |||||||||||||||||||
| Total operating expenses | 74,497 | 64,543 | 211,584 | 197,237 | |||||||||||||||||||
| Income from operations | 79,925 | 58,551 | 179,120 | 122,026 | |||||||||||||||||||
| Other income, net | 9,915 | 4,481 | 26,060 | 15,223 | |||||||||||||||||||
| Income before income taxes | 89,840 | 63,032 | 205,180 | 137,249 | |||||||||||||||||||
| Provision for income taxes | 14,644 | 15,076 | 44,453 | 30,285 | |||||||||||||||||||
| Net income | $ | 75,196 | $ | 47,956 | $ | 160,727 | $ | 106,964 | |||||||||||||||
| Net income per share attributable to Class A and Class B common stockholders: | |||||||||||||||||||||||
| Basic | $ | 0.40 | $ | 0.26 | $ | 0.86 | $ | 0.56 | |||||||||||||||
| Diluted | $ | 0.37 | $ | 0.24 | $ | 0.80 | $ | 0.52 | |||||||||||||||
| Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | |||||||||||||||||||||||
| Basic | 187,161 | 186,309 | 186,344 | 191,302 | |||||||||||||||||||
| Diluted | 202,233 | 200,463 | 200,625 | 207,265 | |||||||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Cost of revenue | $ | 2,818 | $ | 2,466 | $ | 8,373 | $ | 7,205 | |||||||||||||||
| Research and development | 4,471 | 3,080 | 14,602 | 8,874 | |||||||||||||||||||
| Sales and marketing | 6,487 | 4,060 | 19,881 | 12,752 | |||||||||||||||||||
| General and administrative | 5,592 | 2,165 | 11,470 | 6,742 | |||||||||||||||||||
| Restructuring | — | — | — | 3,646 | |||||||||||||||||||
| Total stock-based compensation expense | $ | 19,368 | $ | 11,771 | $ | 54,326 | $ | 39,219 | |||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||||||
| Net income | $ | 75,196 | $ | 47,956 | $ | 160,727 | $ | 106,964 | |||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||
| Depreciation and amortization | 2,655 | 2,509 | 7,830 | 7,717 | |||||||||||||||||||
| Deferred income taxes | 1,992 | — | 2,196 | — | |||||||||||||||||||
| Stock-based compensation, net of amounts capitalized | 19,368 | 11,771 | 54,326 | 39,219 | |||||||||||||||||||
| Non-cash lease expense | 441 | 522 | 1,392 | 1,599 | |||||||||||||||||||
| Accretion of discount on marketable securities, net | (3,368) | (1,683) | (8,736) | (3,477) | |||||||||||||||||||
| Amortization of deferred contract costs | 1,785 | 1,548 | 6,544 | 6,278 | |||||||||||||||||||
Impairment of long-lived assets |
— | — | 2,304 | — | |||||||||||||||||||
| Other | 411 | 1,500 | 289 | 1,627 | |||||||||||||||||||
Changes in operating assets and liabilities: |
|||||||||||||||||||||||
| Accounts receivable | (12,986) | (1,135) | (36,464) | 8,509 | |||||||||||||||||||
| Prepaid expenses and other assets | 1,303 | 6,523 | 21,251 | (3,981) | |||||||||||||||||||
| Deferred contract costs | (5,853) | (4,477) | (9,069) | (6,925) | |||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | 9,418 | 10,429 | 3,872 | 2,366 | |||||||||||||||||||
| Deferred revenue | (24,628) | (24,823) | (30,085) | (38,576) | |||||||||||||||||||
| Operating lease liabilities | (545) | (586) | (1,599) | (1,168) | |||||||||||||||||||
| Net cash provided by operating activities | 65,189 | 50,054 | 174,778 | 120,152 | |||||||||||||||||||
| Cash flows from investing activities | |||||||||||||||||||||||
| Purchases of property and equipment | — | (36) | — | (147) | |||||||||||||||||||
| Internal-use software development costs | (1,771) | (1,288) | (5,018) | (4,020) | |||||||||||||||||||
| Purchases of marketable securities | (164,025) | (101,112) | (531,833) | (281,338) | |||||||||||||||||||
| Maturities of marketable securities | 99,308 | 105,418 | 517,221 | 318,186 | |||||||||||||||||||
| Sales of marketable securities | 7,564 | 37,150 | 14,805 | 74,675 | |||||||||||||||||||
| Net cash provided by (used in) investing activities | (58,924) | 40,132 | (4,825) | 107,356 | |||||||||||||||||||
| Cash flows from financing activities | |||||||||||||||||||||||
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants |
3,662 | 2,540 | 13,905 | 9,758 | |||||||||||||||||||
| Proceeds from issuance of common stock in connection with the employee stock purchase plan | — | — | 1,422 | 1,494 | |||||||||||||||||||
| Taxes paid related to net share settlement of equity awards | (8,107) | (1,248) | (16,329) | (5,332) | |||||||||||||||||||
| Repurchase of common stock | (19,307) | (76,792) | (93,505) | (262,976) | |||||||||||||||||||
| Payment of contingent consideration related to a business combination | — | — | (5,470) | (5,390) | |||||||||||||||||||
Payment of excise taxes on share repurchases |
(1,491) | — | (1,491) | — | |||||||||||||||||||
| Net cash used in financing activities | (25,243) | (75,500) | (101,468) | (262,446) | |||||||||||||||||||
| Net increase (decrease) in cash and cash equivalents | (18,978) | 14,686 | 68,485 | (34,938) | |||||||||||||||||||
| Cash and cash equivalents, beginning of period | 184,248 | 108,403 | 96,785 | 158,027 | |||||||||||||||||||
Cash and cash equivalents, end of period |
$ | 165,270 | $ | 123,089 | $ | 165,270 | $ | 123,089 | |||||||||||||||
| Supplemental disclosures of cash flow information | |||||||||||||||||||||||
Cash paid for taxes, net of refunds |
$ | 13,829 | $ | 8,925 | $ | 35,814 | $ | 38,363 | |||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||
| Net income | $ | 75,196 | $ | 47,956 | $ | 160,727 | $ | 106,964 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | 19,368 | 11,771 | 54,326 | 35,573 | |||||||||||||||||||
| Depreciation and amortization | 2,655 | 2,509 | 7,830 | 7,717 | |||||||||||||||||||
| Provision for income taxes | 14,644 | 15,076 | 44,453 | 30,285 | |||||||||||||||||||
Restructuring and impairment charges |
— | — | 2,304 | 7,936 | |||||||||||||||||||
| Change in fair value of contingent earn-out consideration liability | 90 | 452 | 513 | 768 | |||||||||||||||||||
| Other income, net | (9,915) | (4,481) | (26,060) | (15,223) | |||||||||||||||||||
| Adjusted EBITDA | $ | 102,038 | $ | 73,283 | $ | 244,093 | $ | 174,020 | |||||||||||||||
| Revenue | $ | 168,603 | $ | 135,284 | $ | 432,111 | $ | 357,365 | |||||||||||||||
| Net income margin | 44.6 | % | 35.4 | % | 37.2 | % | 29.9 | % | |||||||||||||||
| Adjusted EBITDA margin | 60.5 | % | 54.2 | % | 56.5 | % | 48.7 | % | |||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Net cash provided by operating activities | $ | 65,189 | $ | 50,054 | $ | 174,778 | $ | 120,152 | |||||||||||||||
| Purchases of property and equipment | — | (36) | — | (147) | |||||||||||||||||||
| Internal-use software development costs | (1,771) | (1,288) | (5,018) | (4,020) | |||||||||||||||||||
| Free cash flow | $ | 63,418 | $ | 48,730 | $ | 169,760 | $ | 115,985 | |||||||||||||||
| Other cash flow components: | |||||||||||||||||||||||
| Net cash provided by (used in) investing activities | $ | (58,924) | $ | 40,132 | $ | (4,825) | $ | 107,356 | |||||||||||||||
| Net cash used in financing activities | $ | (25,243) | $ | (75,500) | $ | (101,468) | $ | (262,446) | |||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| (in thousands, except per share data and percentages) | |||||||||||||||||||||||
| GAAP cost of revenue | $ | 14,181 | $ | 12,190 | $ | 41,407 | $ | 38,102 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | (2,818) | (2,466) | (8,373) | (7,205) | |||||||||||||||||||
| Amortization of acquired intangibles | — | — | — | (274) | |||||||||||||||||||
| Non-GAAP cost of revenue | $ | 11,363 | $ | 9,724 | $ | 33,034 | $ | 30,623 | |||||||||||||||
| GAAP gross profit | $ | 154,422 | $ | 123,094 | $ | 390,704 | $ | 319,263 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | 2,818 | 2,466 | 8,373 | 7,205 | |||||||||||||||||||
| Amortization of acquired intangibles | — | — | — | 274 | |||||||||||||||||||
| Non-GAAP gross profit | $ | 157,240 | $ | 125,560 | $ | 399,077 | $ | 326,742 | |||||||||||||||
| GAAP gross margin | 91.6 | % | 91.0 | % | 90.4 | % | 89.3 | % | |||||||||||||||
| Non-GAAP gross margin | 93.3 | % | 92.8 | % | 92.4 | % | 91.4 | % | |||||||||||||||
| GAAP research and development expense | $ | 22,421 | $ | 19,946 | $ | 68,235 | $ | 61,835 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | (4,471) | (3,080) | (14,602) | (8,874) | |||||||||||||||||||
| Non-GAAP research and development expense | $ | 17,950 | $ | 16,866 | $ | 53,633 | $ | 52,961 | |||||||||||||||
| GAAP sales and marketing expense | $ | 38,491 | $ | 34,956 | $ | 108,102 | $ | 99,612 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | (6,487) | (4,060) | (19,881) | (12,752) | |||||||||||||||||||
| Amortization of acquired intangibles | (1,061) | (1,061) | (3,183) | (3,183) | |||||||||||||||||||
| Change in fair value of contingent earn-out consideration liability | (90) | (452) | (513) | (768) | |||||||||||||||||||
| Non-GAAP sales and marketing expense | $ | 30,853 | $ | 29,383 | $ | 84,525 | $ | 82,909 | |||||||||||||||
| GAAP general and administrative expense | $ | 13,585 | $ | 9,641 | $ | 32,943 | $ | 27,854 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | (5,592) | (2,165) | (11,470) | (6,742) | |||||||||||||||||||
| Non-GAAP general and administrative expense | $ | 7,993 | $ | 7,476 | $ | 21,473 | $ | 21,112 | |||||||||||||||
| GAAP operating expense | $ | 74,497 | $ | 64,543 | $ | 211,584 | $ | 197,237 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | (16,550) | (9,305) | (45,953) | (28,368) | |||||||||||||||||||
| Amortization of acquired intangibles | (1,061) | (1,061) | (3,183) | (3,183) | |||||||||||||||||||
| Change in fair value of contingent earn-out consideration liability | (90) | (452) | (513) | (768) | |||||||||||||||||||
Restructuring and impairment charges |
— | — | (2,304) | (7,936) | |||||||||||||||||||
| Non-GAAP operating expense | $ | 56,796 | $ | 53,725 | $ | 159,631 | $ | 156,982 | |||||||||||||||
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| (in thousands, except per share data and percentages) | |||||||||||||||||||||||
| GAAP operating income | $ | 79,925 | $ | 58,551 | $ | 179,120 | $ | 122,026 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | 19,368 | 11,771 | 54,326 | 35,573 | |||||||||||||||||||
| Amortization of acquired intangibles | 1,061 | 1,061 | 3,183 | 3,457 | |||||||||||||||||||
| Change in fair value of contingent earn-out consideration liability | 90 | 452 | 513 | 768 | |||||||||||||||||||
Restructuring and impairment charges |
— | — | 2,304 | 7,936 | |||||||||||||||||||
| Non-GAAP operating income | $ | 100,444 | $ | 71,835 | $ | 239,446 | $ | 169,760 | |||||||||||||||
| GAAP net income | $ | 75,196 | $ | 47,956 | $ | 160,727 | $ | 106,964 | |||||||||||||||
| Adjusted to exclude the following: | |||||||||||||||||||||||
| Stock-based compensation | 19,368 | 11,771 | 54,326 | 35,573 | |||||||||||||||||||
| Amortization of acquired intangibles | 1,061 | 1,061 | 3,183 | 3,457 | |||||||||||||||||||
| Change in fair value of contingent earn-out consideration liability | 90 | 452 | 513 | 768 | |||||||||||||||||||
Restructuring and impairment charges |
— | — | 2,304 | 7,936 | |||||||||||||||||||
Income tax effect of non-GAAP adjustments (1) |
(4,309) | (2,790) | (12,668) | (10,024) | |||||||||||||||||||
| Non-GAAP net income | $ | 91,406 | $ | 58,450 | $ | 208,385 | $ | 144,674 | |||||||||||||||
| Non-GAAP net income margin | 54.2 | % | 43.2 | % | 48.2 | % | 40.5 | % | |||||||||||||||
| Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | |||||||||||||||||||||||
| Basic | 187,161 | 186,309 | 186,344 | 191,302 | |||||||||||||||||||
| Diluted | 202,233 | 200,463 | 200,625 | 207,265 | |||||||||||||||||||
| Non-GAAP net income per share attributable to Class A and Class B stockholders: | |||||||||||||||||||||||
| Basic | $ | 0.49 | $ | 0.31 | $ | 1.12 | $ | 0.76 | |||||||||||||||
| Diluted | $ | 0.45 | $ | 0.29 | $ | 1.04 | $ | 0.70 | |||||||||||||||